ABCF3 Inhibitors are a specialized class of chemical compounds that target the ABCF3 protein, a member of the ATP-binding cassette (ABC) family, which is known for its role in various cellular processes, including protein synthesis and the regulation of ribosome function. These inhibitors are designed to interact specifically with the ABCF3 protein, typically by binding to its nucleotide-binding domains or other critical regions involved in its function. The binding of these inhibitors can interfere with the protein's ability to hydrolyze ATP, a process essential for its role in modulating cellular activities. By blocking ATP binding or hydrolysis, ABCF3 Inhibitors can effectively alter the conformation of the protein, thereby inhibiting its normal function. This interaction is usually highly selective, with the inhibitors being crafted to precisely fit into the active or allosteric sites of ABCF3, ensuring that their effects are targeted specifically to this protein without affecting other members of the ABC family.
The chemical properties of ABCF3 Inhibitors, including their molecular size, hydrophobicity, and charge distribution, are critical in determining their effectiveness in binding to the ABCF3 protein. These inhibitors often feature molecular structures that mimic the natural ligands or substrates of ABCF3, allowing them to compete effectively for binding sites. Additionally, the inhibitors may incorporate specific functional groups that enhance their binding affinity through hydrogen bonding, van der Waals interactions, or ionic bonds with key residues within the protein's binding domains. The solubility and stability of these compounds are also important considerations, as they influence the inhibitor's ability to reach and interact with ABCF3 in its native cellular environment. Understanding the binding kinetics, including how quickly the inhibitor associates with and dissociates from the protein, is crucial for determining the overall impact of the inhibitor on ABCF3 activity. By studying these interactions, researchers can gain a deeper understanding of the molecular mechanisms that govern protein synthesis and other essential cellular processes in which ABCF3 plays a key role.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Verapamil | 52-53-9 | sc-507373 | 1 g | $374.00 | ||
Calcium channel blocker that also inhibits ABC transporters. Can potentially affect ABCF3's ATP-binding or hydrolysis activities. | ||||||
Cyclosporin A | 59865-13-3 | sc-3503 sc-3503-CW sc-3503A sc-3503B sc-3503C sc-3503D | 100 mg 100 mg 500 mg 10 g 25 g 100 g | $63.00 $92.00 $250.00 $485.00 $1035.00 $2141.00 | 69 | |
Immunosuppressant that inhibits certain ABC transporters. May indirectly influence ABCF3 by affecting related transport mechanisms. | ||||||
Probenecid | 57-66-9 | sc-202773 sc-202773A sc-202773B sc-202773C | 1 g 5 g 25 g 100 g | $28.00 $39.00 $100.00 $277.00 | 28 | |
Inhibits organic anion transporters and some ABC transporters. If ABCF3 has similar motifs or functions, its activity can be modulated by Probenecid. | ||||||
Fumitremorgin C | 118974-02-0 | sc-202162 | 250 µg | $408.00 | 5 | |
Specific inhibitor of ABCG2 transporter. Given structural similarities within ABC family, it can potentially modulate ABCF3's activity. | ||||||
Quinidine | 56-54-2 | sc-212614 | 10 g | $104.00 | 3 | |
Antiarrhythmic agent that inhibits certain ABC transporters. Can potentially affect ABCF3's ATP-binding or hydrolysis activities. | ||||||
Elacridar | 143664-11-3 | sc-207613A sc-207613 sc-207613B sc-207613C sc-207613D | 5 mg 10 mg 50 mg 100 mg 1 g | $98.00 $113.00 $411.00 $525.00 $2606.00 | 19 | |
Inhibitor of P-glycoprotein and ABCG2. ABCF3 function can be affected due to structural or functional similarities within the ABC family. | ||||||
Ko 143 | 461054-93-3 | sc-204030 sc-204030A | 1 mg 10 mg | $109.00 $261.00 | 21 | |
Specific ABCG2 inhibitor. Considering the structural resemblance in the ABC family, ABCF3's activity can be influenced. | ||||||
(±)-Sulfinpyrazone | 57-96-5 | sc-202822 sc-202822A | 1 g 5 g | $42.00 $94.00 | 2 | |
Uricosuric agent known to inhibit certain ABC transporters. May modulate ABCF3's function based on similarities in transporter mechanisms. | ||||||
PSC 833 | 121584-18-7 | sc-361298 sc-361298A sc-361298B sc-361298C sc-361298D | 1 mg 10 mg 50 mg 100 mg 1 g | $217.00 $738.00 $2572.00 $4338.00 $27422.00 | 12 | |
Specific inhibitor of P-glycoprotein, can modulate ABCF3 function based on structural or functional similarities within the ABC family. | ||||||